About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.
minkabu the infonoid
(C) 2024 MINKABU THE INFONOID, Inc.
kabutan

DNA Chip Research, Last Fiscal Year Ordinary Profit Revised Downward by 53%

Fri Apr 11, 2025 4:00 pm JST Revision

2397 DNA Chip Research Inc. 【J-GAAP】

Guidance Update Report

DNA Chip Research Inc. <2397> [TSE Std] announced a performance revision after the market closed on April 11th (16:00). The ordinary profit (non-consolidated) for the fiscal year ending March 2025 has decreased 53.0%, from the previous forecast of 100 million yen to 47 million yen (compared to a loss of 245 million yen in the previous period).

Based on the downwardly revised full-year plan announced by the company, our calculation indicates that the October to March period (2H) ordinary profit has decreased 40.8%, from the previous forecast of 130 million yen to 77 million yen (compared to a loss of 85 million yen in the same period of the previous year).

Kabutan News

Guidance Update

Second Half Update

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2024 Prev 660 130 130 96 14.2 0 Nov 7, 2024 J-GAAP
Oct - Mar, 2024 New 651 77 77 2 0.3 0 Apr 11, 2025 J-GAAP
Revision Rate -1.4% -40.8% -40.8% -97.9% -97.9%

Full Year Update

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2025 Prev 1,100 100 100 65 9.6 0 May 10, 2024 J-GAAP
Mar, 2025 New 1,091 47 47 -29 -4.3 0 Apr 11, 2025 J-GAAP
Revision Rate -0.8% -53.0% -53.0%

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2023 326 -98 -85 -87 -13.7 0 May 10, 2024 J-GAAP
Oct - Mar, 2024 Guidance 651 77 77 2 0.3 0 Apr 11, 2025 J-GAAP
YoY +99.7%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2023 327 -362 -365 -362 -61.8 0 May 11, 2023 J-GAAP
Mar, 2024 490 -258 -245 -248 -39.1 0 May 10, 2024 J-GAAP
Mar, 2025 Guidance 1,091 47 47 -29 -4.3 0 Apr 11, 2025 J-GAAP
YoY +122.7% +88.3% +89.0%

Related Articles